INOVOTION - Which molecule will stand out ?
  • Drug discovery services
    • Efficacy & Toxicity
    • Target Validation
    • Only Toxicity
  • Our technology
    • A Unique In Vivo Technology
    • F.A.Q.
  • Your benefits
    • FAST
    • SENSITIVE
    • RELIABLE
    • AFFORDABLE
    • Summary of Benefits
  • Resources & Webinars
    • Publications
    • Newsletter
    • Poster
    • Request documents
    • Webinars
    • White Paper
  • News & Events
  • About us
    • History
    • Mission & Vision
    • Customers
    • Partners
    • Legals
  • Contact

Close menu

 

 

Efficacy & Toxicity
Target Validation
Toxicity Assays
Multi Cancer Screening
webinar_xavier2
webinar_claireprunier-540x303

News & Events

  • Feb 18

    2021

    <b>Available online</b> <br>WHITE PAPER : A GAME-CHANGING PRECLINICAL TESTING MODEL  FOR SYNERGISTIC IMMUNO-ONCOLOGY DRUG CANDIDATES

    Available online
    WHITE PAPER : A GAME-CHANGING PRECLINICAL TESTING MODEL FOR SYNERGISTIC IMMUNO-ONCOLOGY DRUG CANDIDATES

    A standardized in vivo plateform: in ovo human tumor xenografts This white paper reviews the current benefits of immuno-oncology therapeutic strategies over conventional treatments and highlights the main difficulty facing drug developers today: the high combinatorial […]

  • Feb 16

    2021

    <b>Register for free</b> <br> Fast and cost-effective solutions for <em>in vivo</em> anticancer drug evaluation, using the chicken embryo model

    Register for free
    Fast and cost-effective solutions for in vivo anticancer drug evaluation, using the chicken embryo model

    Wed, Mar 24, 2021 | 4:00 PM GMT Xavier Rousset, PhD, R&D Team Leader Sponsored by INOVOTION   Preclinical oncology assays using classical models such as the mouse suffer from several limitations which significantly hamper overall […]

  • Jan 19

    2021

    INOVOTION WILL ATTEND THE PREDICT : TUMOR MODELS FOR IMMUNO-ONCOLOGY SUMMIT

    INOVOTION WILL ATTEND THE PREDICT : TUMOR MODELS FOR IMMUNO-ONCOLOGY SUMMIT

    Equip Your Preclinical I/O Studies with Robust Models to Enable Enhanced Clinical Relevancy & Translatability   As the only industry-focused meeting dedicated to preclinical scientists and translational oncologists in the immunotherapy space, the PREDiCT Series […]

Contact

contact@inovotion.com

France : +33 (0)476 549 512
USA : +1 (617) 230-6738

DOWNLOAD
THE BROCHURE

Inovotion logo
INOVOTION SAS 
Biopolis - 5 Avenue du grand sablon - 38700 La Tronche - France
Phone: +33 476 549 512
Fax: +33 476 549 511
contact@inovotion.com
INOVOTION INC.
185 Alewife Brook Parkway, Suite 210, Cambridge, MA 02138, USA
Phone: +1 (617) 230-6738
contact@inovotion.com


Newsletter


Our publications